Skip to main content

Beware a conflict of interest

has asked contributors to declare potential conflicts of interest, including disclosure of sources of funding.

Written byDavid Nicholson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

One of the World's leading science journals this week bowed to mounting pressure and asked contributors to declare potential conflicts of interest, including disclosure of financial interests. Phillip Campbell, editor of Nature, which previously did not have a financial disclosure policy, issued a statement on 23 August 2001 titled 'Declaration of financial interests'. In the statement, he introduces a new policy for authors of research papers in Nature.

Campbell states there is evidence to suggest that publication practices in biomedical research have been influenced by the commercial interests of authors. He also voices a general concern in the scientific community of the possible undermining of the integrity of scientific research by increasing commercial links and consequent influences.

Concerns about conflicts of interest in science hit the headlines earlier this year following publication in the spring of a study by Tufts University in Science and Engineering Ethics. It found that only ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation